Skip to content
by Legal Desire
13 August 2024

Latham & Watkins Advises scPharmaceuticals on Growth Financings

Advising firms

Deal team

14 lawyers named
LawyerFirmSeniorityPracticeOffice
Haim Zaltzman Lead Latham & Watkins LLP Partner Not stated Not stated
Dan Van Fleet Lead Latham & Watkins LLP Partner Not stated Not stated
Erin Cusenbary Latham & Watkins LLP Associate Not stated Not stated
Tony Noh Latham & Watkins LLP Associate Not stated Not stated
Ian Drazen Latham & Watkins LLP Associate Not stated Not stated
Kirt Switzer Latham & Watkins LLP Partner tax Not stated
Gregory Conyers Latham & Watkins LLP Associate tax Not stated
Jekkie Kim Latham & Watkins LLP Partner healthcare and life sciences Not stated
Mizuna Sekine Latham & Watkins LLP Associate healthcare and life sciences Not stated
Patrick Chew Latham & Watkins LLP Associate healthcare and life sciences Not stated
Betty Pang Latham & Watkins LLP Partner FDA regulatory Not stated
Chad Jennings Latham & Watkins LLP Counsel FDA regulatory Not stated
Josh Friedman Latham & Watkins LLP Partner ERISA Not stated
Wesley Holmes Latham & Watkins LLP Partner corporate Not stated

11 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 125m (US$125 million)
What the figure measures
Facility amount
Client
scPharmaceuticals Inc.Borrower
Counterparties
Perceptive Advisors (Lenders)